Skip to main page content

Dr. Wai-Ching Lam

Uczestniczy w 43 elementy

Dr. Wai-Ching Lam is the Head of the Ophthalmology Department of Vancouver General Hospital, and the Medical Director of Ophthalmology of the UBC Hospital

Dr. Lam is a vitreo-retinal surgeon with clinical interests in adult and pediatric retinal diseases. For his clinical and scientific work, he received the Achievement Award from the American Academy of Ophthalmology and Asian Pacific Academy of Ophthalmology, and Fellow and the Senior Honor Award from the American Society of Retinal Specialists. 

He is a committed medical educator and won 16 teaching awards in 18 years from the Faculty of Medicine and the Department of Surgery, and Ophthalmology and Vision Sciences while at the University of Toronto. 

He has published over 100 peer-reviewed articles. He has also authored 7 book chapters, and recently co-edit a new book, “A Quick Guide Pediatric Retina”, Springer 2021. 

Financial disclosure: Dr. Lam has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon
  2. Allergan
  3. Bayer
  4. Novartis
  5. Roche

 

Elementy, w których Dr. Wai-Ching Lam uczestniczy

sobota 2 czerwiec, 2018

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
13:35
13:35 - 14:00 | 25 min.

niedziela 16 czerwiec, 2019

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
13:30
13:30 - 15:00 | 1 godz. 30 min.
Retina
13:35
13:35 - 13:50 | 15 min.
Retina

sobota 26 czerwiec, 2021

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
17:30
17:30 - 19:00 | 1 godz. 30 min.
Retina
18:30
18:30 - 19:00 | 30 min.
Retina

niedziela 12 czerwiec, 2022

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
5:30
5:30 - 7:00 | 1 godz. 30 min.
Co-Developed Symposium

LEARNING OBJECTIVESAt the end of this symposium, participants will be able to:Identify the critical unmet needs in neovascular AMD and DME managementDemonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME managementExamine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DMEApply new insights from multi-modal imagin...

5:35
5:35 - 5:40 | 5 min.
RetinaCo-Developed Symposium
5:50
5:52 - 5:57 | 5 min.
RetinaCo-Developed Symposium
6:10
6:10 - 6:25 | 15 min.
RetinaCo-Developed Symposium
6:25
6:25 - 6:40 | 15 min.
RetinaCo-Developed Symposium
6:40
6:40 - 6:50 | 10 min.
RetinaCo-Developed Symposium
9:45
9:45 - 11:15 | 1 godz. 30 min.
Retina

Learning ObjectivesAt the end of this session, participants will be able to:Utilize OCT Imaging to differentiate various types of Pigmented Epithelial DetachmentsUtilize OCT Imaging of the choroid...

10:50
10:50 - 11:15 | 25 min.
Retina

piątek 16 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
13:30
13:30 - 15:00 | 1 godz. 30 min.
Retina

 Learning Objectives: At the end of this session, participants will be able to: Assess new therapeutic modalities for dry age-related macular degenerationAssess current therapies for wet age-related macular degenerationAssess complications of anti-VGF treatments and preventative measuresCanMEDS Roles: Medical Expert, Scholar

sobota 17 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
6:30
6:30 - 8:00 | 1 godz. 30 min.
Co-Developed Symposium

*Breakfast to be served from 6:00am* Learning Objectives: At the end of this session, participants will be able to: Outline the role of the Tie-2/ang pathway in DR and nAMDand how it may impact patient outcomesIdentify the most important biomarkerson structural OCT that can help predict treatmentresponse in DME and nAMDDiscuss r...

piątek 20 czerwiec, 2025

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
11:40
11:40 - 11:45 | 5 min.

Author’s Name(s): Wai-Ching Lam, Timothy Lai, Xiaodong Sun, Shih-Jen Chen, Xin Zhang, Andrea Schulze, Tobias Machewitz, Min Zhao, Sergio LealAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Apellis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Novartis, Membership on an advisory panel, standing committee or board of directors, Amgen, Membership on an advi...

15:20
15:20 - 15:25 | 5 min.

Author’s Name(s): Wai-Ching Lam, Shih-Jen Chen, Gemmy Cheung, Tomohiro Iida, Adrian Koh, Won Ki Lee, Paisan Ruamviboonsuk, Xiaodong Sun, Yasuo Yanagi, Timothy LaiAuthor’s Disclosure Block: Wai-Ching Lam: Roche, Grant/research support, Novartis, Membership on an advisory panel, standing committee or board of directors, Bayer, Employment/honoraria/consulting fees, Amgen, Membership on an advisory panel, standing committee or board of directors, Apellis, ...

sobota 21 czerwiec, 2025

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
7:00
7:00 - 8:30 | 1 godz. 30 min.
Co-Developed Symposium

Join us at this Accredited Symposium co-developed with COS and Roche! Chaired by Bernard Hurley and Cynthia Qian.The retinal care symposium is also taking shape. Drawing inspiration from "Who Wants to Be a Millionaire," we are developing an engaging game-show format where specialists tackle increasingly challeng...

11:15
11:15 - 12:45 | 1 godz. 30 min.
Retina

Learning ObjectivesAt the end of this session, participants will be able to:Understand how the home OCT works and its practical application in the management of retinal diseases.

niedziela 22 czerwiec, 2025

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
12:25
12:25 - 12:45 | 20 min.

Attendees will actively participate during this session, engaging in questions and sharing their diagnoses.

Elementy, w których Dr. Wai-Ching Lam attends

piątek 16 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
10:45
10:45 - 12:15 | 1 godz. 30 min.
Retina

Learning Objectives: At the end of this session, participants will be able to: Understand the concept of retinal displacement in retinal detachment repair and the various factors affecting itAssess the use of multi-modal imaging technologies to optimize surgical resultsIntegrate peripheral retinal imaging in the assessment of retinal pathologiesCanMEDS Roles:

15:45
15:45 - 17:15 | 1 godz. 30 min.
Retina

 Learning Objectives: At the end of this session, participants will be able to: Assess the use of multi-modal imaging in assessing retinal pathologyAssess new technologies in imaging of the retinaIntegrate new management strategies for diabetic retinopathyCanMEDS Roles: Medical Expert, Scholar

sobota 17 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)
13:30
13:30 - 15:00 | 1 godz. 30 min.
Skills Transfer Course (STC)Cataract

 Implantation of an IOL in the absence of capsular support remains challenging for many surgeons. Intrascleral haptic fixation using the flanged, double needle (Yamane) technique allows the surgeon to scleral fixate a 3 piece IOL in the setting of complete zonular compromise.  The technique leaves the conjunctiva and sclera relatively undisturbed compared to other scleral fixation techniques while also reducing surgical time. Attendees will ga...

niedziela 18 czerwiec, 2023

Strefa czasowa: (GMT-05:00) Eastern Time (US & Canada)